Publication | Closed Access
A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
97
Citations
27
References
2009
Year
ThrombosisHealth PolicyHealth EconomicsMedicinePolicy ModelRiskbenefit RatioPharmacoeconomicsPharmacotherapyWarfarin Pharmacogenomic TestingCost EffectivenessDrug TrialPublic HealthLaboratory MedicineEpidemiologyPharmacoepidemiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1